Skip to main content
KALV logo
KALV
(NASDAQ)
KalVista Pharmaceuticals, Inc.
$19.90-- (--)
Loading... - Market loading

KalVista Pharmaceuticals (KALV) Balance Sheet

Assets, liabilities, and shareholders' equity with annual and quarterly data.

KalVista Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for KalVista Pharmaceuticals, Inc. (KALV) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period EndingApr 2025Apr 2024Apr 2023Apr 2022Apr 2021Apr 2020Apr 2019Jul 2018Apr 2017
Current Assets
Cash and Cash Equivalents131.6231.7956.2430.7350.5915.7932.0151.0630.95
Short-Term Investments89.00178.6193.14135.47198.3451.9368.810.000.00
Cash & Short-Term Investments220.62210.40149.38166.20248.9367.71100.8151.0630.95
Accounts Receivable10.8718.6418.6416.8111.7216.5311.326.832.55
Inventory0.000.000.000.000.000.000.000.000.00
Other Current Assets4.424.314.3110.643.624.463.421.490.70
Total Current Assets241.69225.69172.33193.65264.2688.70115.5559.3834.25
Non-Current Assets
Property, Plant & Equipment (Net)9.1510.7710.7710.047.553.662.411.840.10
Other Non-Current Assets0.570.110.110.190.200.180.170.170.00
Total Non-Current Assets9.089.7110.8810.237.753.832.592.010.10
Total Assets250.77235.40183.20203.88272.0192.53118.1361.3934.35
Current Liabilities
Accounts Payable9.114.824.823.641.981.682.861.431.15
Short-Term Debt1.981.301.090.980.860.590.050.220.00
Accrued Liabilities12.409.134.922.796.930.000.000.000.00
Deferred Revenue11.000.000.000.000.000.009.5518.480.00
Other Current Liabilities27.3112.409.136.966.935.465.593.091.87
Total Current Liabilities22.8115.0315.0311.589.777.7218.0523.223.02
Non-Current Liabilities
Long-Term Debt4.336.027.157.215.051.060.000.060.00
Other Non-Current Liabilities0.000.000.000.000.000.000.0010.860.00
Total Non-Current Liabilities110.216.027.157.215.051.063.3410.921.15
Total Liabilities155.3828.8222.1818.7914.828.7821.3934.143.02
Stockholders' Equity
Common Stock0.040.030.030.030.020.020.020.010.01
Retained Earnings-469.73-343.08-343.08-250.18-167.84-121.59-92.48-71.66-55.86
Accumulated Other Comprehensive Income-3.49-3.06-3.06-3.86-1.43-1.88-1.93-1.11-2.64
Additional Paid-in Capital753.73679.75507.13439.10426.44207.21191.12100.0189.82
Shares Outstanding49.7642.5234.1724.550.000.000.000.000.00
Total Stockholders' Equity95.39206.58161.03185.09257.1983.7596.7427.2531.33
Total Liabilities & Equity250.77235.40183.20203.88272.0192.53118.1361.3934.35

Frequently Asked Questions About KalVista Pharmaceuticals Balance Sheet

What is a balance sheet?

A balance sheet shows a company's financial position at a specific point in time. It lists total assets (what the company owns), total liabilities (what it owes), and stockholders' equity (the difference). The fundamental equation: Assets = Liabilities + Equity.

What is stockholders' equity?

Stockholders' equity represents the net value belonging to shareholders — total assets minus total liabilities. It includes retained earnings, common stock, and additional paid-in capital. Growing equity over time typically indicates a healthy, profitable business.

What is working capital?

Working capital is current assets minus current liabilities. It measures a company's ability to pay short-term obligations with short-term assets. Positive working capital indicates the company can cover its near-term debts; negative may signal liquidity risk.

What is KALV's debt level?

Review KalVista Pharmaceuticals's total long-term debt and short-term borrowings in the balance sheet table above. Compare debt to equity and total assets to assess leverage and financial risk.

What is book value per share?

Book value per share is total stockholders' equity divided by shares outstanding. It represents the accounting value per share if the company were liquidated. Comparing market price to book value gives the price-to-book (P/B) ratio — a key valuation metric.

These financial metrics are calculated using balance sheet data. Learn how each metric works and screen stocks by them.